# An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

Study · id `cardio:ct-nct03187522` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03187522](<https://clinicaltrials.gov/study/NCT03187522>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03187522

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 174 participants.

## Technical summary

Registry record NCT03187522. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-22 (actual); primary completion 2020-12-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 174 participants (enrolled count; ClinicalTrials.gov record NCT03187522, source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)
- Started: 2017-06-22 (actual) (ClinicalTrials.gov record NCT03187522, source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)
- Primary completion: 2020-12-30 (actual) (ClinicalTrials.gov record NCT03187522, source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)
- Completion: 2020-12-30 (actual) (ClinicalTrials.gov record NCT03187522, source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)
- Countries: Belgium; Germany; Italy; Netherlands; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03187522, source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03187522-2021-03-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft
- Condition: Aortic Aneurysm, Abdominal
- Intervention (Device): TREO Stent-Graft System
- Lead sponsor: Bolton Medical
- Lead sponsor class: INDUSTRY
- Collaborator: Bolton Medical Espana SLU
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Bolton Medical (`cardio:org-bolton-medical`)

## Provenance

Content hash: 5ba26636f17138c9fd4472700a65435bf08ef3645fb5c7ff0933425c0f49b4d0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
